1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Future Horizons and Growth Strategies in the Global Cell Surface Testing Market 2015: Supplier Shares and Country Forecasts

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.


This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.


The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.


Contains 120 pages and 15 tables

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.


This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.

Table Of Contents

Future Horizons and Growth Strategies in the Global Cell Surface Testing Market 2015: Supplier Shares and Country Forecasts

MEDICAL DEVICES PHARMACEUTICALS CHEMICALS FOOD and BEVERAGE ELECTRONICS
Table of Contents and

List of Tables
Copyright VENTURE PLANNING GROUP
This material is confidential for use by our clients only
and may not be reprinted or reproduced.

VPG Publications, Consulting, Clients www.VPGcorp.com
VPG Market Research Reports www.VPGMarketResearch.com
Partner Reports www.LeadingMarketResearch.com
VENTURE PLANNING GROUP 1271 Avenue of the Americas, Suite 4300 New York, NY 10020
Phone + 1 212 564 2838 Fax + 1 212 564 8133 reports@vpgcorp.com
Table of Contents

I. Introduction
II. Worldwide Market and Technology Overview

A. Lymphocyte Subclassification CD4/CD8
° Instrumentation and Reagent Test Kits
* BD
* Beckman Coulter/Danaher
* T Cells Diagnostics
B. CD34
C. Other Cell Markers
D. Instrumentation Review
1. Hematology Analyzers
a. Overview
° Electrical Aperture-Impedance Analyzers
° Light Scatter Analyzers
b. System Review
° Abbott
° Beckman Coulter/Danaher
° Biocode Hycel
° Drew-Scientific
° Horiba
° Menarini
° Nihon Kohden
° Siemens
° Sysmex
2. Flow Cytometers
a. Introduction
b. System Overview
° Becton Dickinson
° Beckman Coulter/Danaher
E. Current Market Needs and Future Demand
For Hematology Analyzers
F. Reagents and Controls
Table of Contents (continued)
G. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
III. France : Forecasts by Test and Market Segment

IV. Germany : Forecasts by Test and Market Segment
V. Italy : Forecasts by Test and Market Segment

VI. Japan : Forecasts by Test and Market Segment
VII. Spain : Forecasts by Test and Market Segment

VIII. U.K. : Forecasts by Test and Market Segment
IX. U.S. : Forecasts by Test and Market Segment

X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
Table of Contents (continued)
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
° Abbott
° Beckman Coulter/Danaher
° Becton Dickinson
° Bio-Rad
° CellaVision
° Dako/Agilent Technologies
° Horiba
° Iris Diagnostics/Danaher
° Nihon Kohden
° Ortho-Clinical Diagnostics
° Roche
° Siemens
° Sysmex

XIII. Appendix: Major Universities and Research
Centers Developing Hematology/Flow Cytometry
Technologies and Applications



List of Tables

France, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
France, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Germany, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Italy, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Italy, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Japan, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Japan, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Spain, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Spain, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Spain, Ambulatory Care Center Estimated
Cell Surface Marker Test Volume
U.K., Hospital Laboratories Estimated
Cell Surface Marker Test Volume
U.K., Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume


U.S., Hospital Laboratories Estimated
Cell Surface Marker Test Volume
U.S., Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
U.S., Physician Office Laboratories Estimated
Cell Surface Marker Test Volume

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Flat-Rate Access to R&D Database & Reports from La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

  • $ 8470
  • Industry report
  • November 2016
  • by La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing - R&D Drug Pipeline Database: 1-Year Subscription - Flat-Rate Subscription to La Merie Publishing Reports & News Services A one-yea ...

Bioprinting: Technologies and Global Markets

Bioprinting: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Understand market dynamics of bioprinting technologies, applications, and end-user industries. - Assess specific bioprinting-related industries, including 3-D cell culture; bioinks; ...

Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

  • $ 6328
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global stem cell assay market is expected to reach USD 1,363.3 million by 2021 from USD 536.6 million in 2016, at a CAGR of 20.5% from 2016 to 2021. Factors such as high prevalence of chronic diseases, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.